calendar
2,520 catalysts · 4,207 phase readout · 2,234 8k filing · 282 earnings · 172 phase 2 completion · 110 drug shortage · 73 phase 1 completion
2,520 catalysts · 4,207 phase readout · 2,234 8k filing · 282 earnings · 172 phase 2 completion · 110 drug shortage · 73 phase 1 completion
no tagged catalysts yet
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 3.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 9.01
Items: 2.02, 7.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02, 8.01, 9.01
Items: 7.01, 9.01
Items: 5.07
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 3.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 5.07
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 1.01
Items: 5.02, 5.07
Anticipated earnings call for Inhibikase Therapeutics, Inc. ($IKT).
Anticipated earnings call for PolyPid Ltd. ($PYPD).
Anticipated earnings call for TAKEDA PHARMACEUTICAL CO LTD ($TAK).
Anticipated earnings call for Inhibikase Therapeutics, Inc. ($IKT).